Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET
- 20 November 2007
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 35 (3) , 502-508
Abstract
This study assessed the ability of visual and quantitative 124-iodine positron emission tomography (124I PET) data to detect disseminated iodine-avid lung metastases (DILM) of differentiated thyroid cancer (DTC). Using “post-therapy” 131-iodine (131I) whole-body scintigraphy (TxWBS) and thoracic computed tomography (CT), we retrospectively divided 70 consecutive DTC patients undergoing 124I PET dosimetry ∼1 week before 131I therapy into subgroups positive (n = 7) or negative (n = 63) for DILM, defined as lung metastases visible on TxWBS but not thoracic CT. To determine whether 124I PET data could distinguish patients with versus without DILM, we compared these data with the TxWBS findings. The 124I PET data were acquired via whole-body PET scans ∼24 h after oral administration of 124I, 24 ± 2 MBq. Quantitative data comprised absolute lung 124I activity concentrations and lung-to-background (L/B) 124I uptake ratios. Only 1/7 DILM-positive patients had visible disseminated lung uptake. Absolute 124I lung uptake activities overlapped considerably between both groups and did not differ significantly (P = 0.150). Mean L/B ratios, however, differed significantly between the DILM-positive and negative groups (P < 0.001). Nevertheless, L/B ratios overlapped between the groups (0.62–1.37 versus 0.13–0.69). Quantitative analysis of 124I PET data using the L/B ratio is a promising tool to detect patients suspicious for DILM. However, L/B ratios overlapped between the groups to an extent that an unequivocal diagnosis based solely on this criterion was impossible in some patients. In those cases, additional diagnostic tests are necessary for diagnosis.Keywords
This publication has 33 references indexed in Scilit:
- 124-Iodine Positron Emission Tomography/Computed Tomography Dosimetry in Pediatric Patients with Differentiated Thyroid CancerExperimental and Clinical Endocrinology & Diabetes, 2007
- Value of 124I-PET/CT in staging of patients with differentiated thyroid cancerEuropean Radiology, 2004
- Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?European Journal of Nuclear Medicine and Molecular Imaging, 2003
- Papillary thyroid cancer with pulmonary metastases in children: Long-term prognosisSurgery, 2000
- Radiation Dose Assessment for I-131 Therapy of Thyroid Cancer Using I-124 PET ImagingClinical Positron Imaging, 1999
- Treatment of Micronodular Lung Metastases of Papillary Thyroid Cancer: Are the Tumors too Small for Effective Irradiation from Radioiodine?Thyroid®, 1998
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Dosimetric Considerations in the Radioiodine Treatment of Macrometastases and Micrometastases from Differentiated Thyroid CancerThyroid®, 1997
- Relation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid CancerNew England Journal of Medicine, 1983